Chiara Pavanello Selected Research

Folic Acid (Vitamin M)

1/2014

Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiara Pavanello Research Topics

Disease

9	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 10/2023 - 01/2017
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2018
6	Hypercholesterolemia 01/2022 - 11/2014
6	Atherosclerosis 01/2021 - 08/2013
5	Homozygous Familial Hypercholesterolemia 01/2022 - 08/2013
4	Dyslipidemias (Dyslipidemia) 06/2023 - 01/2014
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2018
3	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2022 - 08/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2014
2	Chronic Renal Insufficiency 10/2023 - 06/2023
2	Renal Insufficiency (Renal Failure) 07/2023 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2023 - 09/2019
2	Hypertension (High Blood Pressure) 08/2022 - 01/2017
2	Non-alcoholic Fatty Liver Disease 12/2020 - 12/2019
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023
1	COVID-19 01/2023
1	Inflammation (Inflammations) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2022
1	Anemia 08/2022
1	Proteinuria 08/2022
1	Corneal Opacity 08/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 08/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hyperbilirubinemia 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Cholestasis 01/2022
1	Cholangitis 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2022
1	Alagille Syndrome (Alagille-Watson Syndrome) 01/2022
1	Body Weight (Weight, Body) 03/2018
1	Insulin Resistance 12/2017
1	Coronary Disease (Coronary Heart Disease) 06/2016
1	Fatty Liver 11/2014
1	Xanthomatosis (Xanthoma) 08/2013

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 06/2023 - 01/2017
11	CholesterolIBA 11/2023 - 01/2014
11	HDL CholesterolIBA 11/2023 - 06/2016
11	oxidized low density lipoproteinIBA 01/2022 - 08/2013
7	Lipoproteins (Lipoprotein)IBA 07/2023 - 11/2014
6	HDL LipoproteinsIBA 11/2023 - 06/2016
4	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 07/2023 - 06/2016
4	BMS201038IBA 01/2022 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
3	Apolipoproteins B (ApoB)IBA 10/2023 - 03/2018
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2017
3	EnzymesIBA 01/2022 - 01/2019
2	Lipoprotein-XIBA 07/2023 - 01/2022
2	red yeast riceIBA 01/2021 - 01/2014
2	LDL Receptors (LDL Receptor)IBA 12/2019 - 11/2014
2	LDL CholesterolIBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 11/2014 - 08/2013
1	dapagliflozinIBA 10/2023
1	Protein Isoforms (Isoforms)IBA 10/2023
1	Apolipoproteins E (ApoE)IBA 10/2023
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2023
1	Apolipoprotein E3IBA 10/2023
1	Apolipoprotein E4IBA 10/2023
1	Apolipoprotein E2IBA 10/2023
1	Fenofibrate (CiL)FDA LinkGeneric 01/2023
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2022
1	SteroidsIBA 08/2022
1	Hemoglobins (Hemoglobin)IBA 08/2022
1	CreatinineIBA 08/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022
1	BilirubinIBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Sterol O-Acyltransferase 2IBA 01/2022
1	CER-001IBA 01/2022
1	PCSK9 InhibitorsIBA 01/2022
1	multidrug resistance protein 3IBA 01/2022
1	OxysterolsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Fibric Acids (Fibrates)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Plant ProteinsIBA 12/2017
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2017
1	ApolipoproteinsIBA 01/2017
1	Cell Adhesion MoleculesIBA 01/2017
1	policosanolIBA 01/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2014
1	astaxanthine (astaxanthin)IBA 01/2014
1	coenzyme Q10 (CoQ10)IBA 01/2014
1	BerberineIBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2017
2	Blood Component Removal (Apheresis) 01/2021 - 01/2017